Alternative asset manager. $10B+ AUM. Lower middle market PE, early-stage VC, public market strategies. Focused on inefficient markets.

Boston multi-stage VC across healthcare and enterprise software. Backed Veracode, Obalon, Freenome. Partners Terry McGuire and Amir Nashat.

Boston B2B software seed and Series A VC. Community-first model with Core LP network. Backs founders from earliest stages.

Global PE firm. $94B AUM. 420+ companies across 43 countries. 800 Boylston St Boston. Sectors: business/financial services, consumer, healthcare, industrial, retail, tech.

Biotech-only VC building companies from formation. Kendall Square Cambridge. Co-founded Intellia, Translate Bio (acq Sanofi), Horizon (acq Amgen). Partners Bruce Booth and Jean-François Formela.

Audax Group is a private equity firm focused on middle-market buyouts.

Middle-market buyout PE. Buy-and-build strategy. Healthcare, business services, technology. Boston HQ.

La Jolla-based seed/early VC. $750M+ invested across 11 funds. Life sciences and tech. Founded by Kevin Kinsella. 125+ companies. Notable: Vertex, Synaptics, Vocera, Onyx Pharma. WSJ top biotech VC. [merged from 817]: San Diego's pioneering life sciences + tech VC. Founded 1983 by Kevin Kinsella. $750M+ deployed. Separate Avalon BioVentures fund ($135M, 2022) exclusively for early-stage biotech. Managing Partners: Jay Lichter, Sandy Madigan, Tighe Reardon. Accelerator model: incubates companies internally before bringing in co-investors. Notable: Erasca, Janux, Synthorx (acq. Sanofi $2.5B), Calporta (acq. Merck), Nerio (acq. Boehringer-Ingelheim $1.3B).

Global PE mega-fund. $185B AUM. 200 Clarendon St Boston. Sectors: tech, healthcare, consumer, financial services, retail. Co-Managing Partners: John Connaughton, David Gross.

Bain Capital Ventures is a venture capital firm that invests in early-stage and growth-stage startups across seven focus domains: AI Apps, AI Infrastructure, Commerce, Fintech, Healthcare, Physical AI, and Security.

$26.8B AUM. Fund XI closed Oct 2024 at $7.8B — firm record. Middle-market buyouts. Focus: healthcare, software, consumer services. 5 co-founders still active.

Breakthrough Energy is a global platform that invests in and accelerates clean energy innovation across manufacturing, electricity, agriculture, transportation, and building sectors. The organization discovers, develops, and deploys breakthrough technologies aimed at addressing climate change while meeting the world's growing energy demand affordably and reliably.

Investment management and advisory for institutional investors. $500B+ advised. Founded 1973. Focus: private equity, VC, hedge funds, real assets. HQ Boston.

Castor Ventures — Alumni Ventures fund for the MIT community. Co-invests alongside top VCs in MIT-affiliated companies. Part of Alumni Ventures platform ($1.5B AUM, Manchester NH).

Middle-market PE with opportunistic credit and technology strategies. Thematic sourcing, operational improvement. Spun out of Harvard Management Company.

Copley Equity Partners is a private equity firm based in Quincy, Massachusetts, that invests in established small and lower middle-market businesses with growth potential using capital from a single family office. The firm operates independently of traditional private equity fundraising cycles, allowing it to take a long-term approach to investments.

INSUFFICIENT The provided text is primarily navigation menus, location/role selectors, and page structure elements without substantive content describing the Eaton Vance Emerging Markets Debt Opportunities Fund's actual operations or investment strategy.

Public-market crossover / IPO-anchor investor.